Effect of Suppressive Levothyroxine Therapy on Bone Mineral Density in Young Patients with Differentiated Thyroid Carcinoma

Suppressive levothyroxine therapy (sT4) is a cornerstone in the management of differentiated thyroid cancer (DTC). Long-term sT4 may affect bone mineral density (BMD). We evaluated the effect of sT4 on the bone mass of young DTC patients. In this cross-sectional study, BMD was evaluated via dual-ene...

Descripción completa

Detalles Bibliográficos
Autores principales: Zanella, André Borsatto, Marmitt, Laura, Fighera, Tayane Muniz, Scheffel, Rafael Selbach, Spritzer, Poli Mara, Dora, José Miguel, Maia, Ana Luiza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9500704/
https://www.ncbi.nlm.nih.gov/pubmed/36144246
http://dx.doi.org/10.3390/metabo12090842

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9500704/
https://www.ncbi.nlm.nih.gov/pubmed/36144246
http://dx.doi.org/10.3390/metabo12090842

Ejemplares similares